Camp4 Therapeutics Poration Stock Alpha and Beta Analysis
| CAMP Stock | USD 5.41 0.37 6.40% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as CAMP4 THERAPEUTICS PORATION. It also helps investors analyze the systematic and unsystematic risks associated with investing in CAMP4 THERAPEUTICS over a specified time horizon. Remember, high CAMP4 THERAPEUTICS's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to CAMP4 THERAPEUTICS's market risk premium analysis include:
Beta (0.76) | Alpha (3.95) | Risk 8.53 | Sharpe Ratio (0.21) | Expected Return (1.75) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
CAMP4 |
CAMP4 THERAPEUTICS Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. CAMP4 THERAPEUTICS market risk premium is the additional return an investor will receive from holding CAMP4 THERAPEUTICS long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in CAMP4 THERAPEUTICS. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate CAMP4 THERAPEUTICS's performance over market.| α | -3.95 | β | -0.76 |
CAMP4 THERAPEUTICS expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of CAMP4 THERAPEUTICS's Buy-and-hold return. Our buy-and-hold chart shows how CAMP4 THERAPEUTICS performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.CAMP4 THERAPEUTICS Market Price Analysis
Market price analysis indicators help investors to evaluate how CAMP4 THERAPEUTICS stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CAMP4 THERAPEUTICS shares will generate the highest return on investment. By understating and applying CAMP4 THERAPEUTICS stock market price indicators, traders can identify CAMP4 THERAPEUTICS position entry and exit signals to maximize returns.
CAMP4 THERAPEUTICS Return and Market Media
The median price of CAMP4 THERAPEUTICS for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 is 3.95 with a coefficient of variation of 63.55. The daily time series for the period is distributed with a sample standard deviation of 3.83, arithmetic mean of 6.03, and mean deviation of 3.5. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of 487 shares by Jikun Kim of CalAmp Corp at 3.68 subject to Rule 16b-3 | 05/03/2024 |
2 | Global Commercial Vehicle Telematics Industry Research 2024 Market to Reach 37.6 Billion by 2030, Innovation in Telematics Services to Boost Revenue Potential -... | 05/24/2024 |
3 | Disposition of 15 shares by Nathan Lowstuter of CalAmp Corp at 0.8766 subject to Rule 16b-3 | 06/12/2024 |
4 | CAMP4 Therapeutics prices 75MIPO at 11 per share | 10/11/2024 |
5 | Camp4 Therapeutics sees 9.99 million stock purchase by Polaris | 10/15/2024 |
6 | Insider Trading Activity Tuesday Top Buys and Sells in US Stocks Revealed | 10/16/2024 |
7 | Camp4 Therapeutics sees 8.4 million stock purchase by Northpond Ventures | 10/17/2024 |
8 | Disposition of 1448 shares by Clark Jeffrey P. of CAMP4 THERAPEUTICS subject to Rule 16b-3 | 10/18/2024 |
9 | UNDER CANVAS ANNOUNCES FIRST PACIFIC NORTHWEST CAMP IN THE COLUMBIA RIVER GORGE REGION OF WASHINGTON, NEAR OREGONS MOUNT HOOD | 10/22/2024 |
10 | Erykah Badu, Playboi Carti, MF Doom tribute, Sexyy Red and more bring the heat to Camp Flog Gnaw on Day 2 | 11/18/2024 |
About CAMP4 THERAPEUTICS Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including CAMP4 or other stocks. Alpha measures the amount that position in CAMP4 THERAPEUTICS has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | PTB Ratio | 75.92 | 247.81 | 53.7 | 70.11 | Price To Sales Ratio | 19.35 | 12.02 | 1.47 | 1.4 |
CAMP4 THERAPEUTICS Upcoming Company Events
As portrayed in its financial statements, the presentation of CAMP4 THERAPEUTICS's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CAMP4 THERAPEUTICS's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of CAMP4 THERAPEUTICS's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of CAMP4 THERAPEUTICS. Please utilize our Beneish M Score to check the likelihood of CAMP4 THERAPEUTICS's management manipulating its earnings.
| 25th of April 2024 Upcoming Quarterly Report | View | |
| 8th of July 2024 Next Financial Report | View | |
| 29th of February 2024 Next Fiscal Quarter End | View | |
| 25th of April 2024 Next Fiscal Year End | View | |
| 30th of November 2023 Last Quarter Report | View | |
| 28th of February 2023 Last Financial Announcement | View |
Build Portfolio with CAMP4 THERAPEUTICS
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for CAMP4 Stock Analysis
When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.